ProofPilot Welcomes Dr. Roslyn Schneider to Its Advisory Board
ProofPilot, recognized as the industry's first end-to-end Clinical Experience Platform (CXP), is thrilled to announce the appointment of Dr. Roslyn Schneider to its Strategic Advisory Board. This strategic move aims at enhancing recruitment and engagement throughout the clinical study process.
Dr. Schneider's Extensive Experience
Roslyn Schneider presents an impressive portfolio, bringing over 30 years of experience in various capacities, including as a physician, biopharmaceutical executive, and consultant. She is esteemed for her role in launching blockbuster therapies, contributing significantly to patient-centered healthcare innovations. Being a retired Professor of Medicine, she also holds the distinction of being an award-winning author and the chair of the New Jersey Chapter of the American Lung Association.
Aligning With Company Mission
According to Chris Venezia, CEO of ProofPilot, "Roslyn's deep understanding of both the pharmaceutical industry and patient-focused healthcare aligns perfectly with ProofPilot's mission. Having worked with leading pharmaceutical companies, she possesses firsthand insight into the complexities of clinical trials. Her guidance will help us develop solutions that effectively address the evolving needs of our clients." This alignment is crucial in improving the efficacy of clinical trials, which ultimately leads to better patient care.
In her role at ProofPilot, Dr. Schneider will be instrumental in advising on product direction and strategy. Her invaluable understanding of patient affairs will enable the development of innovative solutions designed to enhance patient engagement and recruitment. With her insights, ProofPilot aims to ensure that patient needs remain at the forefront of the clinical trial process—an approach that is essential for improving trial outcomes.
Commitment to Patient-Centric Solutions
Roslyn Schneider expressed her enthusiasm for joining ProofPilot, stating, "Joining ProofPilot feels like a natural extension of my passion for putting patients first. I look forward to leveraging my experience to help shape strategies that not only advance clinical development but also truly make a difference in patients' lives." Her commitment reflects the core values of ProofPilot, where patient engagement and outcomes take precedence.
Future Developments at ProofPilot
As ProofPilot continues to innovate, it will announce additional appointments to its Strategic Advisory Board. These strategic enhancements are designed to ensure that ProofPilot's solutions deliver both immediate and long-term value for all stakeholders involved in clinical trials. The company's proactive approach ensures it remains a leader in the clinical trial space, helping to bridge gaps between stakeholders and improve overall efficiency.
About ProofPilot
ProofPilot enhances clinical trials through its innovative Clinical Experience Platform. The StudyCoPilot platform centralizes and simplifies communication between sponsors, patients, and trial sites, thereby enriching the clinical trial experience. This integration fosters a seamless flow of information, vital for driving successful trial outcomes.
Frequently Asked Questions
What is ProofPilot's primary focus?
ProofPilot focuses on improving the clinical trial process through its Clinical Experience Platform, enhancing recruitment, engagement, and overall trial outcomes.
Who is Dr. Roslyn Schneider?
Dr. Roslyn Schneider is a seasoned physician and biopharmaceutical executive with over 30 years of experience, now serving on ProofPilot's Strategic Advisory Board.
What role will Dr. Schneider play at ProofPilot?
Dr. Schneider will advise on product direction and strategy, ensuring patient needs remain central to the clinical trial process.
Why is patient engagement important in clinical trials?
Patient engagement is crucial as it directly influences the effectiveness of clinical trials, leading to better outcomes and more personalized healthcare solutions.
How does ProofPilot ensure value for stakeholders?
ProofPilot ensures value through its innovative approaches and strategic appointments to its advisory board, focusing on enhancing communication among all parties involved in clinical trials.
